News

Published on 6 Sep 2023 on Exec Edge via Yahoo Finance

Eterna Therapeutics Teams with Lineage Cell on Transplant Therapies


Article preview image

By Daniella Parra

Eterna Therapeutics Inc. (Nasdaq: ERNA) is partnering with Lineage Cell Therapeutics, Inc. to develop stem cell lines for central nervous system diseases, the company said.

NASDAQ.ERNA price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Eterna Therapeutics Appoints Sanjeev Luther as President and CEO

By Healthcare Edge Editorial Staff Eterna Therapeutics Inc. (Nasdaq: ERNA) said it appointed Sanj...

Exec Edge via Yahoo Finance 21 Dec 2023

Eterna Therapeutics Appoints Dr. James Bristol to Board of Directors

By Daniella Parra Eterna Therapeutics Inc. (Nasdaq: ERNA) said it appointed Dr. James Bristol, an...

Exec Edge via Yahoo Finance 2 Nov 2023

Insider Stock Buying Reaches US$2.7m On Eterna Therapeutics

Quite a few insiders have dramatically grown their holdings in Eterna Therapeutics Inc. (NASDAQ:E...

Simply Wall St. via Yahoo Finance 8 Sep 2023

EXCLUSIVE: Cell Therapy Player Lineage Cell Therapeutics Starts Development Activities Under...

Lineage Cell Therapeutics Inc (NYSE: LCTX) has initiated certain development activities to genera...

Benzinga via Yahoo Finance 6 Sep 2023

Eterna Therapeutics Teams with Lineage Cell on Transplant Therapies

By Daniella Parra Eterna Therapeutics Inc. (Nasdaq: ERNA) is partnering with Lineage Cell Therape...

Exec Edge via Yahoo Finance 6 Sep 2023

Eterna Therapeutics Appoints Dorothy Clarke to Board of Directors

By Healthcare Edge Editorial Staff Eterna Therapeutics Inc. (Nasdaq: ERNA), a life science compan...

Exec Edge via Yahoo Finance 5 Sep 2023

Eterna Therapeutics Announces $8.7M Private Placement Transaction

By Daniella Parra Eterna Therapeutics Inc. (Nasdaq: ERNA), announced the successful completion of...

Exec Edge via Yahoo Finance 18 Jul 2023

Eterna Therapeutics Appoints Industry Veterans Binder, Wagner to Board of Directors

Richard Wagner and Brant Binder By Daniella Parra

Exec Edge via Yahoo Finance 11 Jul 2023

Eterna Therapeutics Appoints Megan Yung as CSO, General Counsel

By Daniella Parra Eterna Therapeutics Inc. (Nasdaq: ERNA) said it named Megan Yung as Chief Strat...

Exec Edge via Yahoo Finance 24 May 2023

Eterna Therapeutics Buys Allogeneic Immuno-Oncology Platform from Exacis

  <img alt="" src="https://s.yimg.com/ny/api/res/1.2/UQ4kiCL34cEHt2UZeYR8lg--/YXBwaWQ9aGlnaGxhbmR...

Exec Edge via Yahoo Finance 3 May 2023